Abstract Details
|
Stela Lefter, MD
PRESENTER |
No disclosure on file |
| Orla Hardiman, MD, FRCP, FAAN (Trinity Biomedical Sciences Institute) | Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB. |
| No disclosure on file | |
| Sinead M. Murphy, MD (Tallaght Hospital) | Dr. Murphy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. Murphy has received research support from Genomics Medicine Ireland. The institution of Dr. Murphy has received research support from Novartis. |
| Michael A. Farrell, MB | No disclosure on file |
| Aisling Ryan, PhD, MB, FRCPI | Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. |
| Paulo P. Fontoura, MD, PhD, FAAN | Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals. |